Delaware Supreme Court upholds Fresenius/Akorn decision

Delaware’s highest state court has confirmed that healthcare company Fresenius was entitled to pull out of its multibillion-dollar acquisition of Akorn after finding that the generic drugmaker had misrepresented the state of its data.